|
|
Session 33-Symposium
Pathways toward a Cure: Viral Latency and Reservoirs
Wednesday, 4-6 pm; Room 6D |
| 106 |
HIV Latency and Eradication: Clinical Perspectives
Sharon Lewin
Burnet Inst, The Alfred Hosp and Monash Univ, Melbourne, Australia |
| 107 |
The Role of Non-human Primate Models in the Evaluation of ARV Suppression, Residual Virus, and Viral Eradication Strategies in AIDS Virus Infection
Jeff Lifson
AIDS and Cancer Virus Prgm, SAIC-Frederick, Inc, NCI-Frederick, MD, US |
| 108 |
Overcoming Pharmacologic Sanctuaries
Courtney Fletcher
Univ of Nebraska Med Ctr, Omaha, US |
| 109 |
The HIV-1 Eradication Pipeline: Challenges and Opportunities
Daria Hazuda
Merck Res Labs, West Point, PA, US |
|
|
